Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Magnus Wall

36 indexed publications match this author name.

ORCID: 0000-0002-0493-6274
OpenAlex: https://openalex.org/A5069665617

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Depression 21 Brain Imaging 18 Aging 15 Receptor Pharmacology 15 Emotional Processing 10 Treatment-Resistant Depression 9 Pharmacology 9 Mechanism of Action 7 Addiction 6 Clinical Trial 5 Anxiety 4 Observational Study 3

Journals

Molecular psychiatry 3 medRxiv 2 bioRxiv 2 Journal of psychopharmacology (Oxford, England) 2 PsyArXiv 2 European Neuropsychopharmacology 2 Neuropharmacology 2 ClinicalTrials.gov 1

Publication history

A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10 Patient perceptions towards psychedelics for musculoskeletal pain: A cross-sectional surveymedRxiv · 2026-06-01 Human brain changes after first psilocybin useNature Communications · 2026-05-05 Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises.Molecular psychiatry · 2025-07-01 Correction: Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises.Molecular psychiatry · 2025-07-01 A multi-institutional investigation of psilocybin's effects on mouse behavior.bioRxiv: the preprint server for biology · 2025-04-09 BIOLOGICAL ACTIVITY OF PSILOCYBIN EXTRACTS FROM THE FRUITING BODIES OF PSILOCYBE CUBENSIS ANTIOXIDANT AND ANTIMICROBIAL POTENTIALJournal of Microbiology Biotechnology and Food Sciences · 2025-03-13 Effects of escitalopram and psilocybin therapy on mesolimbic resting-state functional connectivity in depressionNeuroscience Applied · 2025-01-01 Human neuroimaging: fMRI.International review of neurobiology · 2025-01-01 High hopes? Precision psychedelic addiction medicine.Frontiers in psychiatry · 2025-01-01 Human brain changes after first psilocybin usebioRxiv · 2024-10-14 Scanning the new frontier of mental health: psychedelic brain imagingThe Biochemist · 2024-03-14 Neuroimaging in psychedelic drug development: past, present, and future.Molecular psychiatry · 2023-09-01 Reduced brain responsiveness to emotional stimuli with escitalopram but not psilocybin therapy for depressionmedRxiv · 2023-06-03 Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression.Journal of psychopharmacology (Oxford, England) · 2023-01-01 Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-17 Neuroimaging in psychedelic drug development: Past, present, and futurePsyArXiv · 2022-06-30 Neuroimaging in psychedelic drug development: Past, present, and futurePsyArXiv · 2022-06-30 Increased global integration in the brain after psilocybin therapy for depression.Nature medicine · 2022-04-01 Increased low-frequency brain responses to music after psilocybin therapy for depressionbioRxiv · 2022-02-15 P.0885 The effect of psilocybin therapy for depression on low-frequency brain activity in response to musicEuropean Neuropsychopharmacology · 2021-12-01 Decreased brain modularity after psilocybin therapy for depression.Research Square · 2021-05-20 Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species.Neuropharmacology · 2020-05-01 Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression.Journal of psychopharmacology (Oxford, England) · 2020-02-01 Richard Alpert (Ram Dass): Harvard psychologist who experimented with psychedelic drugs and became one of America’s most prominent and respected spiritual leadersBMJ · 2020-01-31 P.609 Therapeutic mechanisms of psychedelic drugs: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depressionEuropean Neuropsychopharmacology · 2019-12-01 Psilocybin-assisted therapy of major depressive disorder using Acceptance and Commitment Therapy as a therapeutic frameJournal of Contextual Behavioral Science · 2019-11-05 Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression.Neuropharmacology · 2018-11-01 Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.Scientific reports · 2017-10-13 The Effects of LSD and Psilocin on Anxiety-Related Behaviours in ZebrafishStudent Research Proceedings · 2017-05-15 Psilocybin slows binocular rivalry switching through serotonin modulationJournal of Vision · 2010-03-19 Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans.Psychopharmacology · 2007-12-01 Liquid chromatography-tandem mass spectrometry method for the simultaneous analysis of multiple hallucinogens, chlorpheniramine, ketamine, ritalinic acid, and metabolites, in urine.Journal of analytical toxicology · 2007-10-01 Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors.Journal of cognitive neuroscience · 2005-10-01 Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT2A and 5-HT1A agonist psilocybin.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2005-06-01 The Effects of he Hallucinogenic Serotonin 1A/2A Agonist, Psilocybin, on Binocular Rivalry and Visual Contrast Detection ThresholdsQueensland's institutional digital repository (The University of Queensland) · 2003-12-31

Author directory